IP Library › Granted Patent US 11,209,437
Granted Patent B2
US 11,209,437 · App. 16/318,868 · Granted Dec 28, 2021

Fluorescent probe and preparation method and use thereof

Inventors: Linyong Zhu (Shanghai, CN); Yi Yang (Shanghai, CN); Dasheng Zhang (Shanghai, CN); Zengmin Du (Shanghai, CN); Bingkun Bao (Shanghai, CN); Qiuning Lin (Shanghai, CN); Xianjun Chen (Shanghai, CN); Lipeng Yang (Shanghai, CN); Chunyan Bao (Shanghai, CN); Yihui Ge (Shanghai, CN); Renmei Liu (Shanghai, CN); Zhengda Chen (Shanghai, CN); Sitong Zhang (Shanghai, CN); Ningfeng Li (Shanghai, CN); Xin Hua (Shanghai, CN)
Assignee: FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY
G01N33/582A61K49/00A61K49/0017C07D263/56C07D277/64C07D409/14C07D473/18C07D487/04C07D495/04C07F7/0816C09K11/06G01N21/6428G01N33/533
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,209,437
App. No.
16/318,868
Granted
Dec 28, 2021
Kind
B2
Abstract

Provided are a fluorescent probe and a preparation process and the use thereof. The fluorescent probe is sensitive and specific to viscosity, and can be used for specific fluorescent labeling of proteins, and can also be used for quantification, detection or kinetic studies of proteins, and the imaging of cells, tissues and living bodies.

Claims (36)

1. A fluorescent probe, which has a structure as shown in formula (I);

wherein,

R is selected from

X 1 is selected from hydrogen, a saturated aliphatic straight or branched alkyl group of 1 to 10 carbon atoms,

X 2 is selected from —CH 2 CH 2 CH 2 — or —CH 2 CH 2 O—;

the moiety B is selected from the following Formulas containing the thiophene ring:

and wherein,

R 1 is hydrogen;

R 2 is selected from the group consisting of cyano, carboxyl, a heteroaryl group, or a modified alkyl group; when R 2 is the heteroaryl group, the heteroaryl group is a 5- to 10-membered monocyclic or fused bicyclic ring containing at least one heteroatom selected from N, O, or S in the ring; when R 2 is the modified alkyl group, said modified alkyl group is an alkyl group wherein any carbon atom or the carbon atom with the hydrogen atom thereon together contained is independently replaced with one or more groups selected from —O—, OH, —CO—, a secondary amino group; the modified alkyl group has 1 to 4 carbon atoms;

R 3 is cyano, or

in formula (I), the structural part as shown in formula (I-2) has a structure represented by the following Formula (I-2-b):

wherein, R d is methyl or phenyl.

2. The fluorescent probe according to claim 1 , wherein

the R 2 is selected from the following structures, or a bicyclic fused aromatic ring or fused aromatic heterocyclic ring formed by the following structures themselves or fused with each other:

3. The fluorescent probe according to claim 1 , characterized in that the fluorescent probe is selected from the following structures:

4. A process for preparing the fluorescent probe according to claim 1 , comprising a step of reacting a fluorescent dye of formula (II) with a ligand and a linker:

wherein, after reaction, D′ forms —X 2 —NX 1 -group that bonds to the formula (II′)

5. A fluorescent activated protein specific labeling method, comprising the following steps: contacting the fluorescent probe according to claim 1 with a target protein of a protein tag or a fusion protein tag, labeling reaction taking place at the ligand moiety of the fluorescent probe with the protein tag, and the fluorescent probe is labeled onto the protein tag; optionally, the fluorescent probe is covalently labeled on the protein tag;

optionally, a reaction medium of the labeling reaction is selected from a pure protein solution, a cell lysate or an in situ medium in which the target protein of the protein tag or the fused protein tag is located; optionally, the in situ medium is intracellular media, organelle media, living tissue media, Hood or body fluids.

6. A probe kit comprising the fluorescent probe according to claim 1 , optionally further comprising a biocompatible medium which is at least one selected from dimethyl sulfoxide, a buffer, and physiological saline; optionally the buffer is phosphate buffer.

7. A fluorescent activated protein specific labeling method, comprising the following steps: contacting the fluorescent probe according to claim 1 with a target protein of a protein tag or a fusion protein tag, labeling reaction taking place at the ligand moiety of the fluorescent probe with the protein tag, and the fluorescent probe is labeled onto the protein tag; optionally, the fluorescent probe is covalently labeled on the protein tag;

optionally, a reaction medium of the labeling reaction is selected from a pure protein solution, a cell lysate or an in situ medium in which the target protein of the protein tag or the fused protein tag is located; optionally, the in situ medium is intracellular media, organelle media, living tissue media, blood or body fluids.

8. A fluorescent activated protein specific labeling method, comprising the following steps: contacting the fluorescent probe according to claim 2 with a target protein of a protein tag or a fusion protein tag, labeling reaction taking place at the ligand moiety of the fluorescent probe with the protein tag, and the fluorescent probe is labeled onto the protein tag; optionally, the fluorescent probe is covalent's/labeled on the protein tag;

optionally, a reaction medium of the labeling reaction is selected from a pure protein solution, a cell lysate or an in situ medium in which the target protein of the protein tag or the fused protein tag is located; optionally, the in situ medium is intracellular media, organelle media, living tissue media, blood or body fluids.

9. A fluorescent activated protein specific labeling method, comprising the following steps: contacting the fluorescent probe according to claim 3 with a target protein of a protein tag or a fusion protein tag, labeling reaction taking place at the ligand moiety of the fluorescent probe with the protein tag, and the fluorescent probe is labeled onto the protein tag; optionally, the fluorescent probe is covalently labeled on the protein tag;

optionally, a reaction medium of the labeling reaction is selected from a pure protein solution, a cell lysate or an in situ medium in which the target protein of the protein tag or the fused protein tag is located; optionally, the in situ medium is intracellular media, organelle media, living tissue media, blood or body fluids.

10. A probe kit, comprising the fluorescent probe according to claim 2 ,

optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is at least one selected from dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer includes phosphate buffer.

11. A probe kit, comprising the fluorescent probe according to claim 1 ,

optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is at least one selected from dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer includes phosphate buffer.

12. A probe kit, comprising the fluorescent probe according to claim 3 ,

optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is at least one selected from dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer includes phosphate buffer.

13. The fluorescent probe according to claim 1 , wherein, the structure of the Formula (I-2) is selected from the group consisting of the following Formulas:

14. The fluorescent probe according to claim 1 , wherein

said modified alkyl group is a group containing one or more substituents from C 1 to C 4 alkyl groups, —O—, —O—CO—, or —NH—CO—.

15. The fluorescent probe according to claim 14 , wherein the C 1 to C 4 alkyl groups are methyl, ethyl, propyl, isopropyl, and isobutyl.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2021
From: SHANGHAI GLORY CAPITAL MANAGEMENT, LTD.
To: FLUORESCENCE DIAGNOSIS (SHANGHAI) BIOTECH COMPANY
Reel/Frame 057785/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2020
From: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
To: SHANGHAI GLORY CAPITAL MANAGEMENT., LTD.
Reel/Frame 052795/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2019
From: ZHU, LINYONG; YANG, YI; ZHANG, DASHENG; DU, ZENGMIN; BAO, BINGKUN; LIN, QIUNING; CHEN, XIANJUN; YANG, LIPENG; BAO, CHUNYAN; GE, YIHUI; LIU, RENMEI; CHEN, ZHENGDA; ZHANG, SITONG; LI, NINGFENG; HUA, XIN
To: EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
Reel/Frame 048058/0233 →
Priority Claims (1)
CN 201610573341.7 · Jul 20, 2016 · national
Continuity (1)
Related Publication 20190187144A1 · Jun 20, 2019
Cited By (1)
US 12,613,246